#NACFC2021 – Trikafta Increases Risk of Obesity-related Health Problems

#NACFC2021 – Trikafta Increases Risk of Obesity-related Health Problems

311305

#NACFC2021 – Trikafta Increases Risk of Obesity-related Health Problems

People with cystic fibrosis (CF) who start on the triple therapy Trikafta may be at greater risk of problems associated with excessive weight or obesity, such as metabolic syndrome — a group of disorders known to raise a risk of heart, liver, and kidney disease. “With the approval of triple therapy … weight gain and obesity will likely become more apparent, and therefore adverse syndromes associated with that such as metabolic syndrome may also arise,”…

You must be logged in to read/download the full post.